Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Semin Nucl Med. 2012 May;42(3):208–218. doi: 10.1053/j.semnuclmed.2011.11.003

Figure 3.

Figure 3

Coronal whole-body projection images of a patient who had received an oral barium contrast agent before the PET scan. (A) CT image showing the accumulation of barium contrast agent in the bowel, (B) PET scan after CT attenuation correction showing hot spot of FDG activity just above the bladder at the location of the bowel, and (C) PET scan without CT attenuation correction no longer demonstrating a hot spot above the bladder.